Literature DB >> 33708483

Resting heart rate predicts all-cause mortality in sub-Saharan African patients with heart failure: a prospective analysis from the Douala Heart failure registry (Do-HF).

Anastase Dzudie1,2,3, Blaise Barche2, Sidick Mouliom1, Ariane Nouko2, Raissa Fogue2, Jules Ndjebet4, Serah Abang Makoh5, Joseph Abah6, Armel Djomou7, Archange Nzali2, Clovis Nkoke2, Felicite Kamdem1, Samuel Kingue3,8, Karen Sliwa9, Andre Pascal Kengne10,11.   

Abstract

BACKGROUND: Higher resting heart rate (HR) is associated with mortality amongst Caucasians with heart failure (HF), but its significance has yet to be established in sub-Saharan Africans in whom HF differs in terms of characteristics and etiologies. We assessed the association of HR with all-cause mortality in patients with HF in sub-Saharan Africa.
METHODS: The Douala HF registry (Do-HF) is an ongoing prospective data collection on patients with HF receiving care at four cardiac referral services in Douala, Cameroon. Patients included in this report were followed-up for 12 months from their index admission, for all-cause mortality. We used Cox-regression analysis to study the association of HR with all-cause mortality during follow-up.
RESULTS: Of 347 patients included, 343 (98.8%) completed follow-up. The mean age was 64±14 years, 176 (50.7%) were female, and median admission HR was 85 bpm. During a median follow-up of 12 months, 78 (22.7%) patients died. Mortality increased steadily with HR increase and ranged from 12.2% in the lower quartile of HR (≤69 bpm) to 34.1% in the upper quartile of HR (>100 bpm). Hazard ratio of 12-month death per 10 bpm higher HR was 1.16 (1.04-1.29), with consistent effects across most subgroups, but a higher effect in participants with hypertension vs. those without (interaction P=0.044).
CONCLUSIONS: HR was independently associated with increased risk of all-cause mortality in this study, particularly among participants with hypertension. The implication of this finding for risk prediction or reduction should be actively investigated. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Africa; heart failure (HF); heart rate (HR); mortality; outcome

Year:  2021        PMID: 33708483      PMCID: PMC7944210          DOI: 10.21037/cdt-20-785

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  31 in total

Review 1.  Ethnic differences in cardiovascular disease.

Authors:  Nish Chaturvedi
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

2.  Childhood blood pressure as a predictor of arterial stiffness in young adults: the bogalusa heart study.

Authors:  Shengxu Li; Wei Chen; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Hypertension       Date:  2004-01-26       Impact factor: 10.190

Review 3.  Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics.

Authors:  Julie A Johnson
Journal:  Circulation       Date:  2008-09-23       Impact factor: 29.690

Review 4.  Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies.

Authors:  D Aune; A Sen; B ó'Hartaigh; I Janszky; P R Romundstad; S Tonstad; L J Vatten
Journal:  Nutr Metab Cardiovasc Dis       Date:  2017-04-21       Impact factor: 4.222

5.  Defective cardiac parasympathetic control in patients with heart disease.

Authors:  D L Eckberg; M Drabinsky; E Braunwald
Journal:  N Engl J Med       Date:  1971-10-14       Impact factor: 91.245

6.  Resting Heart Rate Trajectory Pattern Predicts Arterial Stiffness in a Community-Based Chinese Cohort.

Authors:  Shuohua Chen; Weijuan Li; Cheng Jin; Anand Vaidya; Jingli Gao; Hui Yang; Shouling Wu; Xiang Gao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-01       Impact factor: 8.311

7.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

Review 8.  Heart rate as a target of treatment of chronic heart failure.

Authors:  Masatsugu Hori; Hiroshi Okamoto
Journal:  J Cardiol       Date:  2012-08       Impact factor: 3.159

9.  Frontiers in congestive heart failure: Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).

Authors:  David Tepper
Journal:  Congest Heart Fail       Date:  1999 Jul-Aug

Review 10.  Heart rate and outcomes in patients with heart failure with preserved ejection fraction: A dose-response meta-analysis.

Authors:  Xiaoke Shang; Rong Lu; Mei Liu; Shuna Xiao; Nianguo Dong
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

View more
  2 in total

1.  Burden of atrial fibrillation among adults with heart failure in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Valirie Ndip Agbor; Frank-Leonel Tianyi; Leopold Ndemnge Aminde; Clarence Mvalo Mbanga; Saint Just N Petnga; Larissa Pone Simo; Anastase Dzudie; Muchi Ditah Chobufo; Jean Jacques Noubiap
Journal:  BMJ Open       Date:  2022-10-12       Impact factor: 3.006

2.  Using wearable devices to generate real-world, individual-level data in rural, low-resource contexts in Burkina Faso, Africa: A case study.

Authors:  Sophie Huhn; Ina Matzke; Mara Koch; Hanns-Christian Gunga; Martina Anna Maggioni; Ali Sié; Valentin Boudo; Windpanga Aristide Ouedraogo; Guillaume Compaoré; Aditi Bunker; Rainer Sauerborn; Till Bärnighausen; Sandra Barteit
Journal:  Front Public Health       Date:  2022-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.